Your browser doesn't support javascript.
loading
Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation.
Olbryt, Magdalena; Rusin, Aleksandra; Fokt, Izabela; Habryka, Anna; Tudrej, Patrycja; Student, Sebastian; Sochanik, Aleksander; Zielinski, Rafal; Priebe, Waldemar.
Afiliación
  • Olbryt M; Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101, Gliwice, Poland. Magdalena.Olbryt@io.gliwice.pl.
  • Rusin A; Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101, Gliwice, Poland.
  • Fokt I; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Habryka A; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tudrej P; Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101, Gliwice, Poland.
  • Student S; Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101, Gliwice, Poland.
  • Sochanik A; Faculty of Automatic Control, Electronics and Computer Science, Silesian University of Technology, Gliwice, Poland.
  • Zielinski R; Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101, Gliwice, Poland.
  • Priebe W; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Invest New Drugs ; 35(5): 545-555, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28417283
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transcripción Genética / Proteína p53 Supresora de Tumor / Receptores de Somatomedina / Antraciclinas / Proliferación Celular / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2017 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transcripción Genética / Proteína p53 Supresora de Tumor / Receptores de Somatomedina / Antraciclinas / Proliferación Celular / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2017 Tipo del documento: Article País de afiliación: Polonia